Earlier today, Humanigen, Inc. (Nasdaq: HGEN) announced that the FDA had declined its request for emergency use authorization of lenzilumab ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE